Role of neutralizing antibodies in controlling simian foamy virus transmission and infection

Transfusion

Volumn 50, Issue 1, 2010, Pages 200-207

  Williams, Dhanya K ^a   Khan, Arifa S ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ARTICLE; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; COCULTURE; MACACA; NONHUMAN; NUCLEOTIDE SEQUENCE; PASSIVE IMMUNIZATION; POLYMERASE CHAIN REACTION; RECIPIENT; RHESUS MONKEY; SIMIAN FOAMY VIRUS; VIRUS DETECTION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS TRANSMISSION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BLOOD TRANSFUSION; DNA, VIRAL; HUMANS; INDICATOR DILUTION TECHNIQUES; LEUKOCYTE REDUCTION PROCEDURES; MACACA MULATTA; NEUTRALIZATION TESTS; POLYMERASE CHAIN REACTION; RETROVIRIDAE INFECTIONS; SPUMAVIRUS; ZOONOSES;

EID: 73549125595     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02372.x     Document Type: Article

References (41)

1. Wolfe ND, Dunavan CP, Diamond J. Origins of major human infectious disease. Nature 2007 447 : 279 83.
2. Allan JS. Cross-species infection: no news is good news? Nat Med 1998 4 : 644 5.
3. Jones-Engel L, Engel GA, Heidrich J, Chalise M, Poudel N, Viscidi R, Barry PA, Allan JS, Grant R, Kyes R. Temple monkeys and health implications of commensalism, Kathmandu, Nepal. Emerg Infect Dis 2006 12 : 900 6.
4. Murphy HW, Miller M, Ramer J, Travis D, Barbiers R, Wolfe ND, Switzer WM. Implications of simian retroviruses for captive primate population management and the occupational safety of primate handlers. J Zoo Wildl Med 2006 37 : 219 33.
5. Khan AS. Simian foamy virus infection in humans: prevalence and management. Expert Rev Anti Infect Ther 2009 7 : 569 80.
6. Heneine W, Schweizer M, Sandstrom P, Folks T. Human infection with foamy viruses. Curr Top Microbiol Immunol 2003 277 : 181 96.
7. Meiering CD, Linial ML. Historical perspective of foamy virus epidemiology and infection. Clin Microbiol Rev 2001 14 : 165 76.
8. Brooks JI, Rud EW, Pilon RG, Smith JM, Switzer WM, Sandstrom PA. Cross-species retroviral transmission from macaques to human beings. Lancet 2002 360 : 387 8.
9. Schweizer M, Falcone V, Gange J, Turek R, Neumann-Haefelin D. Simian foamy virus isolated from an accidentally infected human individual. J Virol 1997 71 : 4821 4.
10. Mergia A, Leung NJ, Blackwell J. Cell tropism of the simian foamy virus type 1 (SFV-1). J Med Primatol 1996 25 : 2 7.
11. Khan AS, Sears JF, Muller J, Galvin TA, Shahabuddin M. Sensitive assays for isolation and detection of simian foamy retroviruses. J Clin Microbiol 1999 37 : 2678 86.
12. McFarlin DE, Blattner WA. Non-AIDS retroviral infections in humans. Annu Rev Med 1991 42 : 97 105.
13. Boneva RS, Switzer WM, Spira TJ, Bhullar VB, Shanmugam V, Cong ME, Lam L, Heneine W, Folks TM, Chapman LE. Clinical and virological characterization of persistent human infection with simian foamy viruses. AIDS Res Hum Retroviruses 2007 23 : 1330 7.
14. Callahan ME, Switzer WM, Matthews AL, Roberts BD, Heneine W, Folks TM, Sandstrom PA. Persistent zoonotic infection of a human with simian foamy virus in the absence of an intact orf-2 accessory gene. J Virol 1999 73 : 9619 24.
15. Switzer WM, Bhullar V, Shanmugam V, Cong ME, Parekh B, Lerche NW, Yee JL, Ely JJ, Boneva R, Chapman LE, Folks TM, Heneine W. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J Virol 2004 78 : 2780 9.
16. Asquith B, Bangham CR. Quantifying HTLV-I dynamics. Immunol Cell Biol 2007 85 : 280 6.
17. Levy JA. HIV pathogenesis: 25 years of progress and persistent challenges. AIDS 2009 23 : 147 60.
18. Nishimura Y, Igarashi T, Haigwood NL, Sadjadpour R, Donau OK, Buckler C, Plishka RJ, Buckler-White A, Martin MA. Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development. Proc Natl Acad Sci U S A 2003 100 : 15131 6.
19. Putkonen P, Thorstensson R, Ghavamzadeh L, Albert J, Hild K, Biberfeld G, Norrby E. Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature 1991 352 : 436 8.
20. Mascola JR. Defining the protective antibody response for HIV-1. Curr Mol Med 2003 3 : 209 16.
21. Haigwood NL, Watson A, Sutton WF, McClure J, Lewis A, Ranchalis J, Travis B, Voss G, Letvin NL, Hu SL, Hirsch VM, Johnson PR. Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. Immunol Lett 1996 51 : 107 14.
22. Khan AS, Kumar D. Simian foamy virus infection by whole-blood transfer in rhesus macaques: potential for transfusion transmission in humans. Transfusion 2006 46 : 1352 9.
23. Karber G. A contribution of the collective treatment of a pharmacological experimental series. Arch Exp Pathol Pharmakol 1931 162 : 480 3.
24. Jones-Engel L, May CC, Engel GA, Steinkraus KA, Schillaci MA, Fuentes A, Rompis A, Chalise MK, Aggimarangsee N, Feeroz MM, Grant R, Allan JS, Putra A, Wandia IN, Watanabe R, Kuller L, Thongsawat S, Chaiwarith R, Kyes RC, Linial ML. Diverse contexts of zoonotic transmission of simian foamy viruses in Asia. Emerg Infect Dis 2008 14 : 1200 8.
25. Switzer WM, Garcia AD, Yang C, Wright A, Kalish ML, Folks TM, Heneine W. Coinfection with HIV-1 and simian foamy virus in West Central Africans. J Infect Dis 2008 197 : 1389 93.
26. Calattini S, Betsem EB, Froment A, Mauclère P, Tortevoye P, Schmitt C, Njouom R, Saib A, Gessain A. Simian foamy virus transmission from apes to humans, rural Cameroon. Emerg Infect Dis 2007 13 : 1314 20.
27. Wolfe ND, Switzer WM, Carr JK, Bhullar VB, Shanmugam V, Tamoufe U, Prosser AT, Torimiro JN, Wright A, Mpoudi-Ngole E, McCutchan FE, Birx DL, Folks TM, Burke DS, Heneine W. Naturally acquired simian retrovirus infections in central African hunters. Lancet 2004 363 : 932 7.
28. Jones-Engel L, Engel GA, Schillaci MA, Rompis A, Putra A, Suaryana KG, Fuentes A, Beer B, Hicks S, White R, Wilson B, Allan JS. Primate-to-human retroviral transmission in Asia. Emerg Infect Dis 2005 11 : 1028 35.
29. Heneine W, Switzer WM, Sandstrom P, Brown J, Vedapuri S, Schable CA, Khan AS, Lerche NW, Schweizer M, Neumann-Haefelin D, Chapman LE, Folks TM. Identification of a human population infected with simian foamy viruses. Nat Med 1998 4 : 403 7.
30. Falcone V, Schweizer M, Neumann-Haefelin D. Replication of primate foamy viruses in natural and experimental hosts. Curr Top Microbiol Immunol 2003 277 : 161 80.
31. Murray SM, Picker LJ, Axthelm MK, Linial ML. Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression. J Virol 2006 80 : 663 70.
32. Anderson KC, Gorgone BC, Marlink RG, Ferriani R, Essex ME, Benz PM, Groopman JE. Transfusion-acquired human immunodeficiency virus infection among immunocompromised persons. Ann Intern Med 1986 105 : 519 27.
33. Wilson BJ, Shiigi SM, Zeigler JL, Olson LC, Malley A, Howard CF Jr. Transmission of simian acquired immunodeficiency syndrome with a type D retrovirus: immunological aspects. Clin Immunol Immunopathol 1986 41 : 453 60.
34. Brooks JI, Merks HW, Fournier J, Boneva RS, Sandstrom PA. Characterization of blood-borne transmission of simian foamy virus. Transfusion 2007 47 : 162 70.
35. Miyoshi I, Takehara N, Sawada T, Iwahara Y, Kataoka R, Yang D, Hoshino H. Immunoglobulin prophylaxis against HTLV-I in a rabbit model. Leukemia 1992 6 Suppl 1 : 24 6.
36. Sawada T, Iwahara Y, Ishii K, Taguchi H, Hoshino H, Miyoshi I. Immunoglobulin prophylaxis against milkborne transmission of human T cell leukemia virus type I in rabbits. J Infect Dis 1991 164 : 1193 6.
37. Kataoka R, Takehara N, Iwahara Y, Sawada T, Ohtsuki Y, Dawei Y, Hoshino H, Miyoshi I. Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits. Blood 1990 76 : 1657 61.
38. Nishimura Y, Igarashi T, Haigwood N, Sadjadpour R, Plishka RJ, Buckler-White A, Shibata R, Martin MA. Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies. J Virol 2002 76 : 2123 30.
39. Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, Addo M, Gatanaga H, Fujiwara M, Hachiya A, Koizumi H, Kuse N, Oka S, Duda A, Prendergast A, Crawford H, Leslie A, Brumme Z, Brumme C, Allen T, Brander C, Kaslow R, Tang J, Hunter E, Allen S, Mulenga J, Branch S, Roach T, John M, Mallal S, Ogwu A, Shapiro R, Prado JG, Fidler S, Weber J, Pybus OG, Klenerman P, Ndung'u T, Phillips R, Heckerman D, Harrigan PR, Walker BD, Takiguchi M, Goulder P. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009 458 : 641 5.
40. Calattini S, Nerrienet E, Mauclere P, Georges-Courbot MC, Saïb A, Gessain A. Natural simian foamy virus infection in wild-caught gorillas, mandrills and drills from Cameroon and Gabon. J Gen Virol 2004 85 : 3313 7.
41. von Laer D, Neumann-Haefelin D, Heeney JL, Schweizer M. Lymphocytes are the major reservoir for foamy viruses in peripheral blood. Virology 1996 221 : 240 4.